Published in J Thromb Haemost on June 01, 2004
Effect of periodontal treatment on glycemic control of diabetic patients: a systematic review and meta-analysis. Diabetes Care (2010) 3.17
Systematic review of guidelines on cardiovascular risk assessment: Which recommendations should clinicians follow for a cardiovascular health check? Arch Intern Med (2010) 2.82
Gene variants associated with deep vein thrombosis. JAMA (2008) 2.74
The optimal intensity of vitamin K antagonists in patients with mechanical heart valves: a meta-analysis. J Am Coll Cardiol (2003) 2.71
The hemostatic system as a modulator of atherosclerosis. N Engl J Med (2011) 2.54
Activation of inflammation and coagulation after infusion of C-reactive protein in humans. Circ Res (2005) 2.46
Performance of 4 clinical decision rules in the diagnostic management of acute pulmonary embolism: a prospective cohort study. Ann Intern Med (2011) 2.28
Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1. Circ Res (2006) 1.95
Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia. Crit Care Med (2006) 1.82
New fundamentals in hemostasis. Physiol Rev (2013) 1.70
Multiple SNP testing improves risk prediction of first venous thrombosis. Blood (2012) 1.70
Thrombospondin-2 polymorphism is associated with a reduced risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol (2002) 1.62
The relationship between tissue factor and cancer progression: insights from bench and bedside. Blood (2011) 1.61
Role of the factor V Leiden mutation in septic peritonitis assessed in factor V Leiden transgenic mice. Crit Care Med (2006) 1.60
Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation. J Clin Invest (2008) 1.59
Low molecular weight heparin attenuates multiple organ failure in a murine model of disseminated intravascular coagulation. Crit Care Med (2005) 1.58
Statin treatment and the risk of recurrent pulmonary embolism. Eur Heart J (2013) 1.58
Treatment of periodontitis improves the atherosclerotic profile: a systematic review and meta-analysis. J Clin Periodontol (2013) 1.57
Cardiovascular risk assessment in haemophilia patients. Thromb Haemost (2010) 1.57
Use of oral glucocorticoids and the risk of pulmonary embolism: a population-based case-control study. Chest (2013) 1.55
Endothelial activation in lacunar stroke subtypes. Stroke (2010) 1.55
Gene expression profiling identifies C/EBPdelta as a candidate regulator of endotoxin-induced disseminated intravascular coagulation. Am J Respir Crit Care Med (2007) 1.54
Validity and clinical utility of the simplified Wells rule for assessing clinical probability for the exclusion of pulmonary embolism. Thromb Haemost (2009) 1.51
Infection and inflammation and the coagulation system. Cardiovasc Res (2003) 1.49
Patients with antineutrophil cytoplasmic antibodies associated vasculitis in remission are hypercoagulable. J Rheumatol (2013) 1.49
Postoperative ileus is maintained by intestinal immune infiltrates that activate inhibitory neural pathways in mice. Gastroenterology (2003) 1.43
Factor V Leiden, prothrombin G20210A, and risk of sudden coronary death in apparently healthy persons. Am J Cardiol (2002) 1.41
Thrombin-activatable fibrinolysis inhibitor in hypothyroidism and hyperthyroxinaemia. Thromb Haemost (2012) 1.40
The effect of hyperthyroidism on procoagulant, anticoagulant and fibrinolytic factors: a systematic review and meta-analysis. Thromb Haemost (2012) 1.37
IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol (2004) 1.35
Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon. Arch Intern Med (2004) 1.35
Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events. Circulation (2003) 1.22
Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis. Br J Haematol (2002) 1.22
Tissue factor in infection and severe inflammation. Semin Thromb Hemost (2006) 1.20
Is thrombin a key player in the 'coagulation-atherogenesis' maze? Cardiovasc Res (2009) 1.20
Analysis of the storage and secretion of von Willebrand factor in blood outgrowth endothelial cells derived from patients with von Willebrand disease. Blood (2013) 1.18
Hypercoagulable state in Cushing's syndrome: a systematic review. J Clin Endocrinol Metab (2009) 1.17
Activated protein C protects against myocardial ischemia/ reperfusion injury via inhibition of apoptosis and inflammation. Arterioscler Thromb Vasc Biol (2009) 1.15
Effects of human cytomegalovirus infection on the coagulation system. Thromb Haemost (2005) 1.14
Early atherosclerosis exhibits an enhanced procoagulant state. Circulation (2010) 1.14
Cerebral white matter lesions predict both ischemic strokes and myocardial infarctions in patients with established atherosclerotic disease. Atherosclerosis (2005) 1.14
Factor Xa stimulates proinflammatory and profibrotic responses in fibroblasts via protease-activated receptor-2 activation. Am J Pathol (2008) 1.13
Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression. Clin Gastroenterol Hepatol (2006) 1.13
Design of the INTEGRATE study: effectiveness and cost-effectiveness of a cardiometabolic risk assessment and treatment program integrated in primary care. BMC Fam Pract (2014) 1.11
Additional value of procalcitonin for diagnosis of infection in patients with fever at the emergency department. Crit Care Med (2010) 1.11
The hemostatic balance in HIV-infected patients with and without antiretroviral therapy: partial restoration with antiretroviral therapy. AIDS Patient Care STDS (2009) 1.11
A comparative study of the protein C pathway in septic and nonseptic patients with organ failure. Am J Respir Crit Care Med (2007) 1.09
Differential gene expression changes in children with severe dengue virus infections. PLoS Negl Trop Dis (2008) 1.06
Endothelium: interface between coagulation and inflammation. Crit Care Med (2002) 1.06
Mast cell degranulation during abdominal surgery initiates postoperative ileus in mice. Gastroenterology (2004) 1.06
Protease-activated receptor-4 inhibition protects from multiorgan failure in a murine model of systemic inflammation. Blood (2007) 1.05
Treatment with an anti-CD14 monoclonal antibody delays and inhibits lipopolysaccharide-induced gene expression in humans in vivo. J Clin Immunol (2003) 1.05
Infections and endothelial cells. Cardiovasc Res (2003) 1.05
Disseminated intravascular coagulation. Hematol J (2003) 1.05
Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia. Haematologica (2009) 1.03
Experimental melanoma metastasis in lungs of mice with congenital coagulation disorders. J Cell Mol Med (2008) 1.03
Travel and the risk of symptomatic venous thromboembolism. Thromb Haemost (2003) 1.03
Thrombin generation in patients after acute deep-vein thrombosis. Thromb Haemost (2008) 1.02
Automatic mining of the literature to generate new hypotheses for the possible link between periodontitis and atherosclerosis: lipopolysaccharide as a case study. J Clin Periodontol (2007) 1.02
Subclinical hypothyroidism and deep venous thrombosis. A pilot cross-sectional study. Thromb Haemost (2007) 1.01
Inflammatory cytokines as risk factors for a first venous thrombosis: a prospective population-based study. PLoS Med (2006) 1.01
The combination of four different clinical decision rules and an age-adjusted D-dimer cut-off increases the number of patients in whom acute pulmonary embolism can safely be excluded. Thromb Haemost (2011) 1.01
Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy. Gut (2013) 1.00
The effect of initiating combined antiretroviral therapy on endothelial cell activation and coagulation markers in South African HIV-infected individuals. Thromb Haemost (2010) 1.00
Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent manner. Proc Natl Acad Sci U S A (2013) 1.00
Increasing concentrations of prothrombin complex concentrate induce disseminated intravascular coagulation in a pig model of coagulopathy with blunt liver injury. Blood (2011) 1.00
Initiation of health-behaviour change among employees participating in a web-based health risk assessment with tailored feedback. J Occup Med Toxicol (2011) 1.00
Effects of ambient air pollution on hemostasis and inflammation. Environ Health Perspect (2009) 0.99
Blood cell-derived tissue factor influences host response during murine endotoxemia. Blood Cells Mol Dis (2004) 0.99
Effects on cardiovascular disease risk of a web-based health risk assessment with tailored health advice: a follow-up study. Vasc Health Risk Manag (2011) 0.98
Polymorphisms in the protein C gene as risk factor for venous thrombosis. Thromb Haemost (2009) 0.98
PTX3 predicts severe disease in febrile patients at the emergency department. J Infect (2009) 0.96
Benchmark for time in therapeutic range in venous thromboembolism: a systematic review and meta-analysis. PLoS One (2012) 0.96
Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case-control study. Blood (2010) 0.96
Acute pulmonary embolism. Part 2: treatment. Nat Rev Cardiol (2010) 0.96
Inhibition of the tissue factor/factor VIIa pathway does not influence the inflammatory or antibacterial response to abdominal sepsis induced by Escherichia coli in mice. J Infect Dis (2004) 0.96
Vascular malformations as underlying cause of chronic thromboembolism and pulmonary hypertension. J Plast Reconstr Aesthet Surg (2008) 0.94
Absence of platelet-dependent fibrin formation in a patient with Scott syndrome. Thromb Haemost (2009) 0.94
High throughput mRNA profiling highlights associations between myocardial infarction and aberrant expression of inflammatory molecules in blood cells. Blood (2004) 0.94
Accelerated in vivo thrombin formation independently predicts the presence and severity of CT angiographic coronary atherosclerosis. JACC Cardiovasc Imaging (2012) 0.94
Chronic pulmonary embolism in Klippel-Trenaunay syndrome. J Am Acad Dermatol (2011) 0.94
The inflammation and coagulation cross-talk in patients with systemic lupus erythematosus. Blood Coagul Fibrinolysis (2007) 0.94
Thrombin generation and atherosclerosis. J Thromb Thrombolysis (2014) 0.93
Periodontitis is associated with platelet activation. Atherosclerosis (2008) 0.93
Chronic renal failure is accompanied by endothelial activation and a large increase in microparticle numbers with reduced procoagulant capacity. Nephrol Dial Transplant (2011) 0.93
Effects of plasma dilution on tissue-factor-induced thrombin generation and thromboelastography: partly compensating role of platelets. Transfusion (2008) 0.92
Colorectal cancer risk factors in the detection of advanced adenoma and colorectal cancer. Cancer Epidemiol (2013) 0.92
Idarucizumab, a Specific Dabigatran Reversal Agent, Reduces Blood Loss in a Porcine Model of Trauma With Dabigatran Anticoagulation. J Am Coll Cardiol (2015) 0.92
The blood coagulation system as a molecular machine. Bioessays (2003) 0.92
Assessment of thrombin generation II: Validation of the Calibrated Automated Thrombogram in platelet-poor plasma in a clinical laboratory. Thromb Haemost (2008) 0.90
Modulation of mouse coagulation gene transcription following acute in vivo delivery of synthetic small interfering RNAs targeting HNF4α and C/EBPα. PLoS One (2012) 0.90